Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Lapatinib and Capecitabine in the Treatment of Metastatic Pancreatic Cancer.

NCT00962312 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT00962312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00962312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Lapatinib and Capecitabine in the Treatment of Metastatic Pancreatic Cancer.
Lead sponsor
Cancer Trials Ireland
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
Not reported
Enrollment
9 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer